stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Revenue
Stevanato Group S.p.A.'s revenue for fiscal 2025 was $1.3B, up 12.3% from $1.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.4B. Over the past ten years it has ranged from $601.0M (fiscal 2019) to $1.3B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 6 consecutive fiscal years. Stevanato Group S.p.A. ranks 20th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.3B | 12.34% |
| FY2024 | $1.2B | 1.70% |
| FY2023 | $1.2B | 13.34% |
| FY2022 | $1.0B | 3.80% |
| FY2021 | $998.4M | 32.03% |
| FY2020 | $756.2M | 25.83% |
| FY2019 | $601.0M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $375.3M | 6.88% |
| Jun 2026 | $351.1M | 9.67% |
| Mar 2026 | $320.2M | (19.87%) |
| Dec 2025 | $399.6M | 12.75% |
| 22 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MMED MiniMed Group, Inc. compare | $3.0B |
| NVST Envista Holdings Corporation compare | $2.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| STVN Stevanato Group S.p.A. | $1.4B |
| WRBY Warby Parker Inc. compare | $934.7M |
| ATRC AtriCure, Inc. compare | $589.8M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on STVN
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement